Detalhe da pesquisa
1.
The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
Front Oncol
; 12: 836630, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223518
2.
Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.
Pharmaceuticals (Basel)
; 15(6)2022 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35745570
3.
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer.
Biomed Pharmacother
; 146: 112516, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906767
4.
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.
Front Oncol
; 11: 705331, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540671
5.
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study.
Expert Opin Ther Targets
; 25(11): 1007-1016, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846251
6.
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.
Front Oncol
; 10: 1587, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33014808
7.
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.
Front Oncol
; 10: 1073, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32733801